2026年6月最新影响因子数据已更新，欢迎查询使用。如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
体验更多LetPub AI科研工具 >> | |
| 近期推荐： | 热 全流程投稿协助套餐服务 | 热 SCI论文AI润色+人工QC服务 | 热 Springer Nature特刊征稿 | 新 已发表SCI？是时候来Springer出书了！ |
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | EUROPEAN JOURNAL OF CANCER EUR J CANCER （此期刊被最新的JCR期刊SCIE收录） LetPub评分 8.6
60人评分
我要评分
声誉 9.4 影响力 8.3 速度 7.0 | |||||||||||||||||||||
| 期刊ISSN | 0959-8049 | 安装APP，查看期刊最新消息
| ||||||||||||||||||||
| E-ISSN | 1879-0852 | |||||||||||||||||||||
| 2025-2026最新IF （数据来源于网友提供） | 注册或登录后，查看IF | |||||||||||||||||||||
| 实时影响因子 | 截止2026年5月06日：7.84 | |||||||||||||||||||||
| 2025-2026自引率 | 2.5%点击查看自引率趋势图 | |||||||||||||||||||||
| 五年IF （数据来源于网友提供） | 7.805数据由网友[river1565]收集提供 | |||||||||||||||||||||
| h-index | 193 | |||||||||||||||||||||
| CiteScore （ 2026年6月最新版） |
| |||||||||||||||||||||
| 期刊简介 |
| |||||||||||||||||||||
| 期刊官方网站 | https://www.sciencedirect.com/journal/european-journal-of-cancer | |||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||
| 期刊投稿网址 | https://www.editorialmanager.com/EJC | |||||||||||||||||||||
| 作者指南网址 | https://www.sciencedirect.com/journal/european-journal-of-cancer/publish/guide-for-authors | |||||||||||||||||||||
| 该期刊中国学者近期发文 - New | Letter Re: Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the ISTOP study Author: Li, Wenjia; Li, Wenjun Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 241, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116765 Standardising definitions, endpoints, and reporting parameters for clinical studies of stereotactic body radiation therapy in bone metastases: An international Delphi consensus Author: Lee, Shing Fung; Wong, Henry C. Y.; Oldenburger, Eva; Raman, Srinivas; Marta, Gustavo N.; Chan, Adrian W.; Rades, Dirk; van der Linden, Yvette M.; van der Velden, Joanne M.; Nguyen, Quynh-Nhu; Choi, J. Isabelle; Hircock, Caroline; Doccioli, Chiara; Cosma, Claudia; Caini, Saverio; Rembielak, Agata; Vassiliou, Vassilios; Bonomo, Pierluigi; Alcorn, Sara; Johnstone, Candice; Simone, Charles B., II; Hoskin, Peter J.; Chow, Edward; Ryu, Samuel Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 241, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116783 An open-label, two-cohort, phase 1a/b study of weekly irinotecan hydrochloride liposome injection combined with vincristine and temozolomide (NALIRI-VT) in patients with advanced Ewing sarcoma Author: Zhao, Yuwei; Xu, Jie; Yu, Yiyang; Yang, Changjiang; Wang, Weikang; Guo, Yu; He, Fangzhou; Ren, Tingting; Xie, Lu; Tang, Xiaodong Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 240, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116743 Patient-reported outcomes from the LAURA study: osimertinib in patients with unresectable stage III EGFR-mutated non-small cell lung cancer after definitive chemoradiotherapy Author: Arriola, Edurne; Casarini, Ignacio; Ozguroglu, Mustafa; Huang, Meijuan; Takahashi, Toshiaki; Lai, Xiaojing; Goto, Koichi; Maneenil, Kunlatida; Lee, Ki Hyeong; Cobo, Manuel; Valdiviezo, Natalia; Evans, Azura; Bolanos, Ana; Huang, Xiangning; Lai, Rachel; Ramalingam, Suresh S Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 240, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116744 | |||||||||||||||||||||
| 期刊语言要求 | Language Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who feel their English language manuscript may require editing to eliminate possible grammatical or spelling errors and to conform to correct scientific English may wish to use the English Language Editing service. 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足EUROPEAN JOURNAL OF CANCER的语言要求，还能让EUROPEAN JOURNAL OF CANCER编辑和审稿人得到更好的审稿体验，让稿件最大限度地被EUROPEAN JOURNAL OF CANCER编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢（1篇） 。 提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
| 通讯方式 | ELSEVIER SCI LTD, 125 London Wall, London, England, EC2Y 5AS | |||||||||||||||||||||
| 出版商 | Elsevier Ltd | |||||||||||||||||||||
| 涉及的研究方向 | 医学-肿瘤学 | |||||||||||||||||||||
| 出版国家或地区 | ENGLAND | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | Semimonthly | |||||||||||||||||||||
| 出版年份 | 1965 | |||||||||||||||||||||
| 年文章数 | 377点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 43.23% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 90.98% | |||||||||||||||||||||
| 期刊分区表预警名单 | 2026年03月发布的新锐学术版：不在预警名单中 2025年03月发布的2025版：不在预警名单中 2024年02月发布的2024版：不在预警名单中 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2020年12月发布的2020版：不在预警名单中 | |||||||||||||||||||||
  | ||||||||||||||||||||||
| 《新锐期刊分区表》 （ 2026年3月发布） | 点击查看期刊分区表趋势图
| |||||||||||||||||||||
| 期刊分区表 （ 2025年3月升级版） |
| |||||||||||||||||||||
| 期刊分区表 （ 2023年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) 收录数据库： Scopus; Medline Science Citation Index Expanded (SCIE) SCImago Journal Rank (SJR) SNIP | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0959-8049%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 期刊官网数据： 平均Submission to first decision: 9 days; Submission to decision after review: 34 days; Submission to acceptance: 66 days; Acceptance to online publication: 4 days; 网友分享经验： 平均1.0个月 来源Elsevier官网： 平均5.3周 | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： 约28% | |||||||||||||||||||||
| APC文章处理费信息 | 版面费：Article Publishing Charge (APC): USD 4,480 (excluding taxes). The amount you pay may be reduced during submission if applicable. | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在EUROPEAN JOURNAL OF CANCER顺利发表。
快看看作者怎么说吧：服务好评 论文致谢（1篇） 。 提交文稿 | |||||||||||||||||||||
| 在线出版周期 | 来源Elsevier官网： 平均7.3周 | |||||||||||||||||||||
| 编辑信息 | Editor-in-Chief Alexander M. M. Eggermont, MD, PhD University Medical Centre Utrecht, Utrecht, Netherlands Editorial Office EJC Editorial Office Elsevier Ltd, Nielsen House, John Smith Drive, Oxford Business Park South, Oxford OX4 2WB, UK | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Letter Re: Real-world outcomes of immunotherapy discontinuation at two years in advanced non-small cell lung cancer: Final results of the ISTOP study Author: Li, Wenjia; Li, Wenjun Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 241, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116765 PubMed DOI |
| 2. | Standardising definitions, endpoints, and reporting parameters for clinical studies of stereotactic body radiation therapy in bone metastases: An international Delphi consensus Author: Lee, Shing Fung; Wong, Henry C. Y.; Oldenburger, Eva; Raman, Srinivas; Marta, Gustavo N.; Chan, Adrian W.; Rades, Dirk; van der Linden, Yvette M.; van der Velden, Joanne M.; Nguyen, Quynh-Nhu; Choi, J. Isabelle; Hircock, Caroline; Doccioli, Chiara; Cosma, Claudia; Caini, Saverio; Rembielak, Agata; Vassiliou, Vassilios; Bonomo, Pierluigi; Alcorn, Sara; Johnstone, Candice; Simone, Charles B., II; Hoskin, Peter J.; Chow, Edward; Ryu, Samuel Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 241, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116783 PubMed DOI |
| 3. | An open-label, two-cohort, phase 1a/b study of weekly irinotecan hydrochloride liposome injection combined with vincristine and temozolomide (NALIRI-VT) in patients with advanced Ewing sarcoma Author: Zhao, Yuwei; Xu, Jie; Yu, Yiyang; Yang, Changjiang; Wang, Weikang; Guo, Yu; He, Fangzhou; Ren, Tingting; Xie, Lu; Tang, Xiaodong Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 240, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116743 PubMed DOI |
| 4. | Patient-reported outcomes from the LAURA study: osimertinib in patients with unresectable stage III EGFR-mutated non-small cell lung cancer after definitive chemoradiotherapy Author: Arriola, Edurne; Casarini, Ignacio; Ozguroglu, Mustafa; Huang, Meijuan; Takahashi, Toshiaki; Lai, Xiaojing; Goto, Koichi; Maneenil, Kunlatida; Lee, Ki Hyeong; Cobo, Manuel; Valdiviezo, Natalia; Evans, Azura; Bolanos, Ana; Huang, Xiangning; Lai, Rachel; Ramalingam, Suresh S Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 240, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116744 PubMed DOI |
| 5. | Determinants of long-term survival from atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma Author: Lee, Pei-Chang; Cortellini, Alessio; Stefanini, Bernardo; Yoo, Changhoon; Chon, Hong Jae; Cheon, Jaekyung; Kudo, Masatoshi; Nishida, Naoshi; Scheiner, Bernhard; Pinter, Matthias; Lombardi, Pasquale; Fulgenzi, Claudia Angela Maria; D'Alessio, Antonio; Brunetti, Leonardo; Torkpour, Aria; Valenzi, Elena; Crowley, Fionnuala; Marron, Thomas U.; Hsu, Wei-Fan; Celsa, Ciro; Cabibbo, Giuseppe; Camma, Calogero; Galle, Peter Robert; Vivaldi, Caterina; Masi, Gianluca; Sharma, Rohini; Lin, Ryan Po-Ting; Lin, Chun-Yen; Wietharn, Brooke; Saeed, Anwaar; Tovoli, Francesco; Piscaglia, Fabio; Dalbeni, Andrea; Auriemma, Alessandra; Sacerdoti, David; Parisi, Alessandro; Manfredi, Giulia Francesca; Dondo, Andrea; Rimassa, Lorenza; Pirisi, Mario; Schonlein, Martin; von Felden, Johann; Singal, Amit G.; Parkih, Neehar Dilip; Andanamala, Haripriya; Ulahannan, Susanna; Roehlen, Natascha; Thimme, Robert; Huang, Yi-Hsiang; Pinato, David James Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 240, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116749 PubMed DOI |
| 6. | Early and late survival dynamics of immunotherapy combinations in advanced HCC: Anchored indirect comparison of atezolizumab plus bevacizumab versus durvalumab plus tremelimumab Author: Casadei-Gardini, Andrea; Yip, Terry Cheuk-Fung; Vitale, Alessandro; Rossari, Federico; Tada, Toshifumi; Suda, Goki; Shimose, Shigeo; Kudo, Masatoshi; Cheon, Jaekyung; Finkelmeier, Fabian; Lim, Ho Yeong; Presa, Jose; Masi, Gianluca; Yoo, Changhoon; Lonardi, Sara; Piscaglia, Fabio; Kumada, Takashi; Scartozzi, Mario; Tamburini, Emiliano; Foschi, Francesco Giuseppe; Camera, Silvia; Persano, Mara; D'Agata, Alessandra Pia; Ferrara, Michele; Passeri, Laura; Rimassa, Lorenza; Rimini, Margherita Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 240, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116750 PubMed DOI |
| 7. | Translating ctDNA into cutaneous melanoma care: An international expert survey Author: Geidel, Glenn; Fekade, Nathan; Raabe, Katharina; Smit, Daniel J.; Adam, Laura; Heidrich, Isabel; Rünger, Alessandra; Kött, Julian; Zell, Tim; Amaral, Teresa; Ascierto, Paolo A.; Corrie, Pippa; Dummer, Reinhard; Eggermont, Alexander; Guo, Jun; Hassel, Jessica C.; Jalving, Mathilde; Johnson, Douglas B.; Kandolf, Lidija; Kirkwood, John M.; Lebbé, Celeste; Lee, Rebecca; Long, Georgina V; Lorigan, Paul; Malvehy, Josep; Mangana, Joanna; Mohr, Peter; Patel, Sapna P.; Rizos, Helen; Robert, Caroline; Schadendorf, Dirk; Sondak, Vernon K.; Svane, Inge Marie; Wainstein, Alberto; Zager, Jonathan S.; Pantel, Klaus; Hauschild, Axel; Gebhardt, Christoffer Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 239, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116676 PubMed DOI |
| 8. | Implementing a molecular prescreening strategy for tumors without public NGS access in a cancer center network: Results from the PREICO project Author: Sabat, Paula; Ajenjo-Bauza, Maria; Hierro, Cinta; Ruffinelli, Jose Carlos; Gil-Martin, Marta; Ochoa-de-Olza, Maria; Bergamino, Milana; Calvo, Mariona; Soto-Castillo, Juan Jose; Fina, Claudia; Llop, Sandra; Stradella, Agostina; Oliva, Marc; Notario, Lucia; Carcereny, Enric; Teixidor-Vila, Eduard; Domenech, Marta; Jove, Maria; Villanueva, Rafael; Alay, Ania; Azuara, Daniel; Gonzalez-Acosta, Maribel; Otero-Torres, Sara; Gausachs, Mireia; Varela, Mar; Villatoro, Sergi; Solanes, Ares; Teule, Alexandre; Cuadra, Carmen; Moreno, Victor; Nadal, Ernest; Cordero, David; Lazaro, Conxi; Martin-Liberal, Juan Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 239, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116728 PubMed DOI |
| 9. | Population impact of PSA screening: Evidence beyond clinical trials Author: Vaccarella, Salvatore; Li, Mengmeng; Auvinen, Anssi; Dal, Luigino Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116615 PubMed DOI |
| 10. | Clinical utility of large language models in metastatic prostate cancer: A multicenter expert validation for decision support Author: Chen, Yinsong; He, Kangwen; Qu, Weinuo; Ma, Luping; Su, Xing; Liu, Xinqi; Kang, Zhen; Li, Feng; Yan, Junrong; Wang, Zhibo; Li, Jing; Li, Zhen Journal: EUROPEAN JOURNAL OF CANCER. 2026; Vol. 238, Issue , pp. -. DOI: 10.1016/j.ejca.2026.116667 PubMed DOI |
|
|
  | ||||||||||||||||
|
投稿状态统计： 我要评分： | ||||||||||||||||
| 投稿前担心稿件结构或语言不够规范？试试稿件自查工具，一键检测 >> | ||||||||||||||||
|
||||||||||||||||
同领域作者分享投稿经验：共185条 |
||||||||||||||||
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2026 中国: LetPub上海 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
增值电信业务经营许可证：沪B2-20211595 网络文化经营许可证：沪网文[2023]2004-152号
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室
安全保密
投稿信 (Cover Letter) 模板
